Form 8-K - Current report:
SEC Accession No. 0001213900-24-035953
Filing Date
2024-04-25
Accepted
2024-04-25 07:01:58
Documents
65
Period of Report
2024-04-25
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0204620-8k_aldey.htm   iXBRL 8-K 40030
2 SLIDE PRESENTATION OF ALDEYRA THERAPEUTICS, INC. DATED APRIL 25, 2024. ea020462001ex99-1_aldey.htm EX-99.1 64877
3 PRESS RELEASE OF ALDEYRA THERAPEUTICS, INC. DATED APRIL 25, 2024. ea020462001ex99-2_aldey.htm EX-99.2 15939
4 GRAPHIC ex99-1_001.jpg GRAPHIC 245935
5 GRAPHIC ex99-1_002.jpg GRAPHIC 173371
6 GRAPHIC ex99-1_003.jpg GRAPHIC 835001
7 GRAPHIC ex99-1_004.jpg GRAPHIC 298918
8 GRAPHIC ex99-1_005.jpg GRAPHIC 156981
9 GRAPHIC ex99-1_006.jpg GRAPHIC 361094
10 GRAPHIC ex99-1_007.jpg GRAPHIC 360634
11 GRAPHIC ex99-1_008.jpg GRAPHIC 295791
12 GRAPHIC ex99-1_009.jpg GRAPHIC 187129
13 GRAPHIC ex99-1_010.jpg GRAPHIC 406657
14 GRAPHIC ex99-1_011.jpg GRAPHIC 335683
15 GRAPHIC ex99-1_012.jpg GRAPHIC 394831
16 GRAPHIC ex99-1_013.jpg GRAPHIC 183813
17 GRAPHIC ex99-1_014.jpg GRAPHIC 292119
18 GRAPHIC ex99-1_015.jpg GRAPHIC 311742
19 GRAPHIC ex99-1_016.jpg GRAPHIC 164670
20 GRAPHIC ex99-1_017.jpg GRAPHIC 368726
21 GRAPHIC ex99-1_018.jpg GRAPHIC 210399
22 GRAPHIC ex99-1_019.jpg GRAPHIC 338393
23 GRAPHIC ex99-1_020.jpg GRAPHIC 158987
24 GRAPHIC ex99-1_021.jpg GRAPHIC 293840
25 GRAPHIC ex99-1_022.jpg GRAPHIC 250663
26 GRAPHIC ex99-1_023.jpg GRAPHIC 254563
27 GRAPHIC ex99-1_024.jpg GRAPHIC 684237
28 GRAPHIC ex99-1_025.jpg GRAPHIC 296043
29 GRAPHIC ex99-1_026.jpg GRAPHIC 335550
30 GRAPHIC ex99-1_027.jpg GRAPHIC 247607
31 GRAPHIC ex99-1_028.jpg GRAPHIC 163476
32 GRAPHIC ex99-1_029.jpg GRAPHIC 331805
33 GRAPHIC ex99-1_030.jpg GRAPHIC 276056
34 GRAPHIC ex99-1_031.jpg GRAPHIC 164140
35 GRAPHIC ex99-1_032.jpg GRAPHIC 336716
36 GRAPHIC ex99-1_033.jpg GRAPHIC 259141
37 GRAPHIC ex99-1_034.jpg GRAPHIC 247924
38 GRAPHIC ex99-1_035.jpg GRAPHIC 269153
39 GRAPHIC ex99-1_036.jpg GRAPHIC 199156
40 GRAPHIC ex99-1_037.jpg GRAPHIC 170525
41 GRAPHIC ex99-1_038.jpg GRAPHIC 184786
42 GRAPHIC ex99-1_039.jpg GRAPHIC 418612
43 GRAPHIC ex99-1_040.jpg GRAPHIC 416281
44 GRAPHIC ex99-1_041.jpg GRAPHIC 294673
45 GRAPHIC ex99-1_042.jpg GRAPHIC 299892
46 GRAPHIC ex99-1_043.jpg GRAPHIC 283475
47 GRAPHIC ex99-1_044.jpg GRAPHIC 412920
48 GRAPHIC ex99-1_045.jpg GRAPHIC 316222
49 GRAPHIC ex99-1_046.jpg GRAPHIC 303222
50 GRAPHIC ex99-1_047.jpg GRAPHIC 167560
51 GRAPHIC ex99-1_048.jpg GRAPHIC 445470
52 GRAPHIC ex99-1_049.jpg GRAPHIC 399084
53 GRAPHIC ex99-1_050.jpg GRAPHIC 159018
  Complete submission text file 0001213900-24-035953.txt   20926006

Data Files

Seq Description Document Type Size
54 XBRL SCHEMA FILE aldx-20240425.xsd EX-101.SCH 3012
55 XBRL LABEL FILE aldx-20240425_lab.xml EX-101.LAB 34240
56 XBRL PRESENTATION FILE aldx-20240425_pre.xml EX-101.PRE 22357
68 EXTRACTED XBRL INSTANCE DOCUMENT ea0204620-8k_aldey_htm.xml XML 3694
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36332 | Film No.: 24872839
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)